Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction to: Efects of AGEs, sRAGE and HMGB1 on Clinical Outcomes in Multiple Myeloma.
Geduk A, Oztas B, Eryılmaz BH, Demirsoy ET, Menguc MU, Unal S, Mersin S, Polat MG, Aygun K, Yenihayat EM, Albayrak H, Erol HA, Balcı S, Mehtap O, Tarkun P, Hacihanefioglu A. Geduk A, et al. Among authors: polat mg. Indian J Hematol Blood Transfus. 2023 Jul;39(3):518. doi: 10.1007/s12288-023-01626-5. Epub 2023 Jan 18. Indian J Hematol Blood Transfus. 2023. PMID: 37304480 Free PMC article.
Serum calprotectin (S100A8/A9) levels as a new potential biomarker of treatment response in Hodgkin lymphoma.
Şumnu Ş, Mehtap Ö, Mersin S, Toptaş T, Görür G, Gedük A, Ünal S, Polat MG, Aygün K, Yenihayat EM, Albayrak H, Uluköylü Mengüç M, Tarkun P, Hacıhanifioğlu A. Şumnu Ş, et al. Among authors: polat mg. Int J Lab Hematol. 2021 Aug;43(4):638-644. doi: 10.1111/ijlh.13559. Epub 2021 Apr 27. Int J Lab Hematol. 2021. PMID: 33904653 Clinical Trial.
The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-center Real-Life Study.
Ak MA, Sahip B, Geduk A, Ucar MA, Kale H, Hacibekiroglu T, Polat MG, Kalpakci Y, Bolaman AZ, Guvenc B, Ertop S. Ak MA, et al. Among authors: polat mg. Indian J Hematol Blood Transfus. 2022 Apr;38(2):299-308. doi: 10.1007/s12288-021-01458-1. Epub 2021 Jun 26. Indian J Hematol Blood Transfus. 2022. PMID: 35496974 Free PMC article.
Long-Term Efficacy of Erythropoiesis-Stimulating Agents in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Multicenter Real-Life Data.
Aslaner Ak M, Gedük A, Acar İH, Polat MG, Sunu C, Bolaman AZ, Hacıbekiroğlu T, Güvenç B, Ertop Ş. Aslaner Ak M, et al. Among authors: polat mg. Turk J Haematol. 2023 May 29;40(2):92-100. doi: 10.4274/tjh.galenos.2023.2022.0437. Epub 2023 Feb 17. Turk J Haematol. 2023. PMID: 36799095 Free PMC article.
Effects of AGEs, sRAGE and HMGB1 on Clinical Outcomes in Multiple Myeloma.
Geduk A, Oztas B, Eryılmaz BH, Demirsoy ET, Menguc MU, Unal S, Mersin S, Polat MG, Aygun K, Yenihayat EM, Albayrak H, Erol HA, Balcı S, Mehtap O, Tarkun P, Hacihanefioglu A. Geduk A, et al. Among authors: polat mg. Indian J Hematol Blood Transfus. 2023 Apr;39(2):220-227. doi: 10.1007/s12288-022-01574-6. Epub 2022 Oct 17. Indian J Hematol Blood Transfus. 2023. PMID: 37006982 Free PMC article.
Do Alarmins Have a Role in Multiple Myeloma?
Gedük A, Polat MG, Terzi Demirsoy E, Öztaş B, Eryılmaz BH, Yenihayat EM, Albayrak H, Erol HA, Mehtap Ö, Tarkun P, Hacıhanefioğlu A. Gedük A, et al. Among authors: polat mg. Turk J Haematol. 2024 May 30;41(2):83-90. doi: 10.4274/tjh.galenos.2024.2023.0469. Epub 2024 Mar 1. Turk J Haematol. 2024. PMID: 38426298 Free PMC article.
47 results